﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2024v5.2" xsi:schemaLocation="http://www.irs.gov/efile">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-10-07T10:06:29-07:00</ReturnTs>
    <TaxPeriodEndDt>2024-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>203564302</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>Dufault CPA Ltd</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
        <CityNm>Waseca</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>56093</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2024-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>263070514</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>Rosenau Family Research Foundation</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>ROSE</BusinessNameControlTxt>
      <PhoneNum>5078338144</PhoneNum>
      <USAddress>
        <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
        <CityNm>Waseca</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>56093</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>Paul Rosenau</PersonNm>
      <PersonTitleTxt>President</PersonTitleTxt>
      <SignatureDt>2025-05-09</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>Jared J Dufault</PreparerPersonNm>
      <PTIN>P00307631</PTIN>
      <PhoneNum>5078338144</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2024</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="11">
    <IRS990PF documentId="IRS990PF" referenceDocumentId="GeneralExplanation" softwareId="24020490" softwareVersionNum="2024v5.2">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>38091699</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ContriRcvdRevAndExpnssAmt>48000</ContriRcvdRevAndExpnssAmt>
        <InterestOnSavRevAndExpnssAmt>2519</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>2519</InterestOnSavNetInvstIncmAmt>
        <DividendsRevAndExpnssAmt>992668</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>992668</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>922157</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>6330552</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>922157</CapGainNetIncmNetInvstIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="OtherIncomeSchedule2">6272827</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>6261565</OtherIncomeNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>8238171</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>8178909</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>363041</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>47010</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstDsbrsChrtblAmt>316031</CompOfcrDirTrstDsbrsChrtblAmt>
        <PensionEmplBnftRevAndExpnssAmt>88738</PensionEmplBnftRevAndExpnssAmt>
        <PensionEmplBnftNetInvstIncmAmt>10362</PensionEmplBnftNetInvstIncmAmt>
        <PensionEmplBnftDsbrsChrtblAmt>78376</PensionEmplBnftDsbrsChrtblAmt>
        <LegalFeesRevAndExpnssAmt referenceDocumentId="LegalFeesSchedule">763683</LegalFeesRevAndExpnssAmt>
        <LegalFeesNetInvstIncmAmt>763683</LegalFeesNetInvstIncmAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="AccountingFeesSchedule">17960</AccountingFeesRevAndExpnssAmt>
        <AccountingFeesNetInvstIncmAmt>17960</AccountingFeesNetInvstIncmAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="OtherProfessionalFeesSchedule">106037</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesNetInvstIncmAmt>106037</OtherProfFeesNetInvstIncmAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="TaxesSchedule">107808</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>17808</TaxesNetInvstIncmAmt>
        <TravConfMeetingRevAndExpnssAmt>9242</TravConfMeetingRevAndExpnssAmt>
        <TravConfMeetingDsbrsChrtblAmt>9242</TravConfMeetingDsbrsChrtblAmt>
        <PrintingAndPubRevAndExpnssAmt>652</PrintingAndPubRevAndExpnssAmt>
        <PrintingAndPubNetInvstIncmAmt>652</PrintingAndPubNetInvstIncmAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="OtherExpensesSchedule AmortizationSchedule">331240</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>267230</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>61103</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>1788401</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>1230742</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>464752</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>1705137</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>1705137</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>3493538</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>1230742</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>2169889</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>4744633</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>6948167</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>484</CashBOYAmt>
        <CashEOYAmt>484</CashEOYAmt>
        <CashEOYFMVAmt>484</CashEOYFMVAmt>
        <SavAndTempCashInvstBOYAmt>215910</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>321475</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>321475</SavAndTempCashInvstEOYFMVAmt>
        <PrepaidExpensesBOYAmt>7523</PrepaidExpensesBOYAmt>
        <PrepaidExpensesEOYAmt>90599</PrepaidExpensesEOYAmt>
        <PrepaidExpensesEOYFMVAmt>90599</PrepaidExpensesEOYFMVAmt>
        <CorporateStockBOYAmt>27811734</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="InvestmentsCorpStockSchedule">32373287</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>35371825</CorporateStockEOYFMVAmt>
        <OtherInvestmentsBOYAmt>2255922</OtherInvestmentsBOYAmt>
        <OtherInvestmentsEOYAmt referenceDocumentId="InvestmentsOtherSchedule2">2255922</OtherInvestmentsEOYAmt>
        <OtherInvestmentsEOYFMVAmt>2307316</OtherInvestmentsEOYFMVAmt>
        <TotalAssetsBOYAmt>30291573</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>35041767</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>38091699</TotalAssetsEOYFMVAmt>
        <AccountsPayableBOYAmt>759</AccountsPayableBOYAmt>
        <AccountsPayableEOYAmt>1220</AccountsPayableEOYAmt>
        <GrantsPayableBOYAmt>1339690</GrantsPayableBOYAmt>
        <GrantsPayableEOYAmt>1500359</GrantsPayableEOYAmt>
        <DeferredRevenueEOYAmt>5100</DeferredRevenueEOYAmt>
        <TotalLiabilitiesBOYAmt>1340449</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>1506679</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowFASB117Ind>X</OrgDoesNotFollowFASB117Ind>
        <CapitalStockBOYAmt>28138467</CapitalStockBOYAmt>
        <CapitalStockEOYAmt>28178467</CapitalStockEOYAmt>
        <RetainedEarningBOYAmt>812657</RetainedEarningBOYAmt>
        <RetainedEarningEOYAmt>5356621</RetainedEarningEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>28951124</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>33535088</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>30291573</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>35041767</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>28951124</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>4744633</ExcessRevenueOverExpensesAmt>
        <SubtotalAmt>33695757</SubtotalAmt>
        <OtherDecreasesAmt referenceDocumentId="OtherDecreasesSchedule">160669</OtherDecreasesAmt>
        <TotNetAstOrFundBalancesEOYAmt>33535088</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>100,000.000 Government Money Market</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-09-09</AcquiredDt>
          <SoldDt>2024-09-18</SoldDt>
          <GrossSalesPriceAmt>100000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>100000</CostOrOtherBasisAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>650,000.000 Government Money Market</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-09-09</AcquiredDt>
          <SoldDt>2024-10-23</SoldDt>
          <GrossSalesPriceAmt>650000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>650000</CostOrOtherBasisAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>125,000.000 Government Money Market</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-09-09</AcquiredDt>
          <SoldDt>2024-11-20</SoldDt>
          <GrossSalesPriceAmt>125000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>125000</CostOrOtherBasisAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>650,000.000 Government Money Market</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-09-09</AcquiredDt>
          <SoldDt>2024-12-13</SoldDt>
          <GrossSalesPriceAmt>650000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>650000</CostOrOtherBasisAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>424.000 Intl Small-Cap Value ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-01-05</AcquiredDt>
          <SoldDt>2024-05-07</SoldDt>
          <GrossSalesPriceAmt>28028</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>26119</CostOrOtherBasisAmt>
          <GainOrLossAmt>1909</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1909</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>1,624.000 US Small-Cap Value ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-09-09</AcquiredDt>
          <SoldDt>2024-11-11</SoldDt>
          <GrossSalesPriceAmt>170353</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>146887</CostOrOtherBasisAmt>
          <GainOrLossAmt>23466</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>23466</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,391.821 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-03-21</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>104689</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>93004</CostOrOtherBasisAmt>
          <GainOrLossAmt>11685</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>11685</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>367.000 USA Quality Factor ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-12-20</AcquiredDt>
          <SoldDt>2024-04-09</SoldDt>
          <GrossSalesPriceAmt>59508</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>53563</CostOrOtherBasisAmt>
          <GainOrLossAmt>5945</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>5945</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>304.000 USA Momentum Factor ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-12-20</AcquiredDt>
          <SoldDt>2024-02-27</SoldDt>
          <GrossSalesPriceAmt>54891</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>46963</CostOrOtherBasisAmt>
          <GainOrLossAmt>7928</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>7928</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>275.000 USA Momentum Factor ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-12-20</AcquiredDt>
          <SoldDt>2024-05-07</SoldDt>
          <GrossSalesPriceAmt>50460</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>42483</CostOrOtherBasisAmt>
          <GainOrLossAmt>7977</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>7977</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>1,228.000 Emerging Mkts ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-12-26</AcquiredDt>
          <SoldDt>2024-05-14</SoldDt>
          <GrossSalesPriceAmt>66244</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>61167</CostOrOtherBasisAmt>
          <GainOrLossAmt>5077</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>5077</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,252.000 Intl Developed Mkts ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-01-05</AcquiredDt>
          <SoldDt>2024-05-14</SoldDt>
          <GrossSalesPriceAmt>152898</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>140994</CostOrOtherBasisAmt>
          <GainOrLossAmt>11904</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>11904</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,460.000 Intl Value Factor ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2024-01-05</AcquiredDt>
          <SoldDt>2024-05-14</SoldDt>
          <GrossSalesPriceAmt>71352</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>65237</CostOrOtherBasisAmt>
          <GainOrLossAmt>6115</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>6115</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,563.421 US High Relative Prof</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-12-31</AcquiredDt>
          <SoldDt>2024-02-22</SoldDt>
          <GrossSalesPriceAmt>56334</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>27967</CostOrOtherBasisAmt>
          <GainOrLossAmt>28367</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>28367</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>21,350.536 Emerging Mkts Core</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-12-31</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>471415</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>411003</CostOrOtherBasisAmt>
          <GainOrLossAmt>60412</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>60412</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>23,785.264 Emerging Mkts Core</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-08-18</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>525173</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>602253</CostOrOtherBasisAmt>
          <GainOrLossAmt>-77080</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-77080</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,333.306 Emerging Mkts Core</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-12-31</AcquiredDt>
          <SoldDt>2024-05-14</SoldDt>
          <GrossSalesPriceAmt>55966</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>44917</CostOrOtherBasisAmt>
          <GainOrLossAmt>11049</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>11049</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>12.973 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2017-12-18</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>568</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>486</CostOrOtherBasisAmt>
          <GainOrLossAmt>82</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>82</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>132.487 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2017-12-18</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>5799</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4966</CostOrOtherBasisAmt>
          <GainOrLossAmt>833</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>833</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>7.474 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2017-12-18</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>327</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>280</CostOrOtherBasisAmt>
          <GainOrLossAmt>47</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>47</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>1,221.559 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-02-06</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>53467</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>45000</CostOrOtherBasisAmt>
          <GainOrLossAmt>8467</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>8467</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>3,484.053 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-02-21</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>152495</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>130000</CostOrOtherBasisAmt>
          <GainOrLossAmt>22495</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>22495</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,829.076 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-10-11</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>123827</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>106123</CostOrOtherBasisAmt>
          <GainOrLossAmt>17704</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>17704</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>581.781 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-05-01</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>25464</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>20000</CostOrOtherBasisAmt>
          <GainOrLossAmt>5464</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>5464</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>225.211 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-12-17</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>9857</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7745</CostOrOtherBasisAmt>
          <GainOrLossAmt>2112</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2112</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>4,793.385 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-03-12</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>209804</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>100000</CostOrOtherBasisAmt>
          <GainOrLossAmt>109804</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>109804</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>826.107 US Small-Cap Value Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-12-14</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>36158</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>32970</CostOrOtherBasisAmt>
          <GainOrLossAmt>3188</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3188</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>15,741.072 Intl Value III Port</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-03-12</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>270579</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>155530</CostOrOtherBasisAmt>
          <GainOrLossAmt>115049</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>115049</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>2,207.927 US Large Cap Value III</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-10-11</AcquiredDt>
          <SoldDt>2024-04-09</SoldDt>
          <GrossSalesPriceAmt>69341</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>57672</CostOrOtherBasisAmt>
          <GainOrLossAmt>11669</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>11669</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>1,243.000 Intl Developed Mkts ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-04-02</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>58511</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>40298</CostOrOtherBasisAmt>
          <GainOrLossAmt>18213</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>18213</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>14,000.000 Intl Developed Mkts ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-04-02</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>659013</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>453740</CostOrOtherBasisAmt>
          <GainOrLossAmt>205273</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>205273</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>5,120.000 Intl Developed Mkts ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-10-27</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>241010</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>208512</CostOrOtherBasisAmt>
          <GainOrLossAmt>32498</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>32498</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>3,699.000 US Small-Cap Value ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-11-10</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>649650</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>477503</CostOrOtherBasisAmt>
          <GainOrLossAmt>172147</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>172147</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>90.000 US Small-Cap Value ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-29</AcquiredDt>
          <SoldDt>2024-01-05</SoldDt>
          <GrossSalesPriceAmt>15807</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>14805</CostOrOtherBasisAmt>
          <GainOrLossAmt>1002</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1002</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>77.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-29</AcquiredDt>
          <SoldDt>2024-02-22</SoldDt>
          <GrossSalesPriceAmt>19345</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>15849</CostOrOtherBasisAmt>
          <GainOrLossAmt>3496</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3496</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>180.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-29</AcquiredDt>
          <SoldDt>2024-04-09</SoldDt>
          <GrossSalesPriceAmt>46332</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>37049</CostOrOtherBasisAmt>
          <GainOrLossAmt>9283</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>9283</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>388.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-29</AcquiredDt>
          <SoldDt>2024-05-07</SoldDt>
          <GrossSalesPriceAmt>99449</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>79862</CostOrOtherBasisAmt>
          <GainOrLossAmt>19587</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>19587</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>88.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-29</AcquiredDt>
          <SoldDt>2024-05-14</SoldDt>
          <GrossSalesPriceAmt>22830</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>18113</CostOrOtherBasisAmt>
          <GainOrLossAmt>4717</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4717</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>247.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-11-10</AcquiredDt>
          <SoldDt>2024-06-25</SoldDt>
          <GrossSalesPriceAmt>66349</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>44653</CostOrOtherBasisAmt>
          <GainOrLossAmt>21696</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>21696</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>14.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-03-29</AcquiredDt>
          <SoldDt>2024-06-25</SoldDt>
          <GrossSalesPriceAmt>3761</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2882</CostOrOtherBasisAmt>
          <GainOrLossAmt>879</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>879</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>208.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-01-05</AcquiredDt>
          <SoldDt>2024-06-25</SoldDt>
          <GrossSalesPriceAmt>55873</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>39521</CostOrOtherBasisAmt>
          <GainOrLossAmt>16352</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>16352</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>147.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-10-27</AcquiredDt>
          <SoldDt>2024-09-04</SoldDt>
          <GrossSalesPriceAmt>39910</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25471</CostOrOtherBasisAmt>
          <GainOrLossAmt>14439</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>14439</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>10.000 Total Stk Mkt ETF</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-11-10</AcquiredDt>
          <SoldDt>2024-09-04</SoldDt>
          <GrossSalesPriceAmt>2715</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1808</CostOrOtherBasisAmt>
          <GainOrLossAmt>907</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>907</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>922157</CapitalGainNetIncomeAmt>
        <NetShortTermCapitalGainLossAmt>82006</NetShortTermCapitalGainLossAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>96580</InvestmentIncomeExciseTaxAmt>
        <SubtotalAmt>96580</SubtotalAmt>
        <TaxBasedOnInvestmentIncomeAmt>96580</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>107068</EstimatedPlusOvpmtIncmTxAmt>
        <TotalPaymentsAndCreditsAmt>107068</TotalPaymentsAndCreditsAmt>
        <Form2220AttachedInd referenceDocumentId="IRS2220">X</Form2220AttachedInd>
        <EsPenaltyAmt>29</EsPenaltyAmt>
        <OverpaymentAmt>10459</OverpaymentAmt>
        <AppliedToESTaxAmt>10459</AppliedToESTaxAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>false</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>false</MoreThan100SpentInd>
        <Form1120POLFiledInd>false</Form1120POLFiledInd>
        <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>false</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>true</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>true</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>MN</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>true</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>false</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>false</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>false</OwnControlledEntityInd>
        <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>true</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>www.rosenaufoundation.org</WebsiteAddressTxt>
        <PersonsWithBooksName>
          <BusinessNameLine1Txt>Dufault CPA Ltd</BusinessNameLine1Txt>
        </PersonsWithBooksName>
        <PhoneNum>5078338144</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
          <CityNm>Waseca</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>56093</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>false</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>false</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>false</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>false</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>false</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>false</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>false</PaymentToGovernmentOfficialInd>
        <ActsFailToQlfyAsExceptionsInd>false</ActsFailToQlfyAsExceptionsInd>
        <UncorrectedPriorActsInd>false</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>false</UndistributedIncomePYInd>
        <BusinessHoldingsInd>false</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>false</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>false</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>false</InfluenceLegislationInd>
        <InfluenceElectionInd>false</InfluenceElectionInd>
        <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>false</NoncharitablePurposeInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Paul Rosenau</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>President</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>5.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Gillian Hauboldt</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Treasurer</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Mary Kay Delvo Amanda Post</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Secretary</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Heather Techmeier</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>188041</CompensationAmt>
          <EmployeeBenefitProgramAmt>28388</EmployeeBenefitProgramAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Dr Gabriel Cohn</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>175000</CompensationAmt>
          <EmployeeBenefitProgramAmt>34615</EmployeeBenefitProgramAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Julie McCarrier</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Li Ou</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Phil Christianson</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Marci Sontag</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>Karlita Blackwell</PersonNm>
          <USAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </USAddress>
          <TitleTxt>Director</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>2.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <CompOfHghstPdCntrctOrNONETxt>NONE</CompOfHghstPdCntrctOrNONETxt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>31949371</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>227023</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>2274501</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>34450895</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>34450895</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>516763</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>33934132</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>1696707</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>1696707</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>96580</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>96580</TotalTaxAmt>
        <DistributableBeforeAdjAmt>1600127</DistributableBeforeAdjAmt>
        <RecoveriesQualfiedDistriAmt>11262</RecoveriesQualfiedDistriAmt>
        <DistributableBeforeDedAmt>1611389</DistributableBeforeDedAmt>
        <DistributableAsAdjustedAmt>1611389</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>2169889</ExpensesAndContributionsAmt>
        <QualifyingDistributionsAmt>2169889</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>1611389</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>255774</UndistributedIncomePYAmt>
        <QualifyingDistributionsAmt>2169889</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>255774</AppliedToYear1Amt>
        <TreatedAsDistriFromCorpusAmt>0</TreatedAsDistriFromCorpusAmt>
        <AppliedToCurrentYearAmt>1611389</AppliedToCurrentYearAmt>
        <RemainingDistriFromCorpusAmt>302726</RemainingDistriFromCorpusAmt>
        <TotalCorpusAmt>302726</TotalCorpusAmt>
        <UndistributedIncomeCYAmt>0</UndistributedIncomeCYAmt>
        <ExcessDistriCyovToNextYrAmt>302726</ExcessDistriCyovToNextYrAmt>
        <ExcessFromCurrentYearAmt>302726</ExcessFromCurrentYearAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <ContributingManagerNm>Paul Rosenau</ContributingManagerNm>
        <ApplicationSubmissionInfoGrp>
          <RecipientPersonNm>Paul Rosenau</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>104 10th Avenue SE</AddressLine1Txt>
            <CityNm>Waseca</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>56093</ZIPCd>
          </RecipientUSAddress>
          <RecipientPhoneNum>5078338144</RecipientPhoneNum>
          <RecipientEmailAddressTxt>info@dufaultcpa.com</RecipientEmailAddressTxt>
          <FormAndInfoAndMaterialsTxt>Letter Outlining Project - Including Financial Data</FormAndInfoAndMaterialsTxt>
          <SubmissionDeadlinesTxt>None</SubmissionDeadlinesTxt>
          <RestrictionsOnAwardsTxt>Childhood Diseases and Newborn Screening for Disease - Particularly Krabbe's and Cystic Fibrosis</RestrictionsOnAwardsTxt>
        </ApplicationSubmissionInfoGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function</GrantOrContributionPurposeTxt>
          <Amt>85000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A Maladaptive Pathway Involved In Early Pathogenesis of KD</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>Biomedical Research Institute of NJ</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>140 East Hanover Avenue</AddressLine1Txt>
            <CityNm>Cedar Knools</CityNm>
            <StateAbbreviationCd>NJ</StateAbbreviationCd>
            <ZIPCd>07927</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Psychosine Profiling and Evaluation as a Therapeutic for KD</GrantOrContributionPurposeTxt>
          <Amt>149154</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Buffalo</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>520 Lee Entrance Suite 211</AddressLine1Txt>
            <CityNm>Amherst</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>14228</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Modulating Oligodendroglial NFkB as a Therapeutic Strategy for KD</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Connecticut Health Ce</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>263 Farmington Avenue</AddressLine1Txt>
            <CityNm>Farmington</CityNm>
            <StateAbbreviationCd>CT</StateAbbreviationCd>
            <ZIPCd>06030</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Evaluation of Immunomodulatory Therapy for the Treatment of KD</GrantOrContributionPurposeTxt>
          <Amt>175049</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>KrabbeConnect</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>PO Box 264</AddressLine1Txt>
            <CityNm>Rosemount</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55068</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Parent-Reported Disease Burden in Infantile &amp; Late Infantile KD</GrantOrContributionPurposeTxt>
          <Amt>123982</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>Nationwide Children's Hospital</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>575 Childrens Crossroads</AddressLine1Txt>
            <CityNm>Columbus</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>43215</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Evaluation of In Utero Gene Therapy in Canine KD</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Pennsylvania</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>3451 Walnut Street 5th Floor</AddressLine1Txt>
            <CityNm>Philadelphia</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19104</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Elucidating the Mechanisms Underlying Macrophage Dysfunction in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Dysfunction of Brain Synapsis in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Effects of Motor Learning on Efficacy and Safety of AAV-Gene Therapy in KD</GrantOrContributionPurposeTxt>
          <Amt>60000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Kansas</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>2060 W 39th Ave</AddressLine1Txt>
            <CityNm>Kansas City</CityNm>
            <StateAbbreviationCd>KS</StateAbbreviationCd>
            <ZIPCd>66103</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Improving Developmental Outcomes in Mouse Models of KD</GrantOrContributionPurposeTxt>
          <Amt>59593</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>Duke University</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>40 Duke Medicine Circle 124 Davison</AddressLine1Txt>
            <CityNm>Durham</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27710</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Pittsburgh</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>116 Atwood St Suite 201</AddressLine1Txt>
            <CityNm>Pittsburgh</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>15213</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Disclosure of Newborn Screening Results for KD in Pennsylvania</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>University of Minnesota</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>200 Oak Street SE Suite 450</AddressLine1Txt>
            <CityNm>Minneapolis</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55455</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GenoKrabbe: A Comprehensive Genotype-Phenotype Database for KD</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientPersonNm>Mayo Clinic</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>200 First Street SW</AddressLine1Txt>
            <CityNm>Rochester</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Elucidating the Metabolic Signature of KD Plasma, Dried Blood Spots, and Cerebrospinal Fluid Using Flux Analysis</GrantOrContributionPurposeTxt>
          <Amt>57359</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>1705137</TotalGrantOrContriPdDurYrAmt>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>Duke University</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>40 Duke Medicine Circle 124 Davison</AddressLine1Txt>
            <CityNm>Durham</CityNm>
            <StateAbbreviationCd>NC</StateAbbreviationCd>
            <ZIPCd>27710</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function</GrantOrContributionPurposeTxt>
          <Amt>85000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Illinois</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>1747 W Roosevelt Road Suite 302</AddressLine1Txt>
            <CityNm>Chicago</CityNm>
            <StateAbbreviationCd>IL</StateAbbreviationCd>
            <ZIPCd>60608</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>A Maladaptive Pathway Involved In Early Pathogenesis of KD</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>Nationwide Children's Hospital</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>575 Childrens Crossroads</AddressLine1Txt>
            <CityNm>Columbus</CityNm>
            <StateAbbreviationCd>OH</StateAbbreviationCd>
            <ZIPCd>43215</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Evaluation of In Utero Gene Therapy in Canine KD</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Buffalo</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>520 Lee Entrance Suite 211</AddressLine1Txt>
            <CityNm>Amherst</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>14228</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Modulating Oligodendroglial NFkB as a Therapeutic Strategy for KD</GrantOrContributionPurposeTxt>
          <Amt>125000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Pittsburgh</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>116 Atwood St Suite 201</AddressLine1Txt>
            <CityNm>Pittsburgh</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>15213</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Disclosure of Newborn Screening Results for KD in Pennsylvania</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>University of Minnesota</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>200 Oak Street SE Suite 450</AddressLine1Txt>
            <CityNm>Minneapolis</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55455</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>GenoKrabbe: A Comprehensive Genotype-Phenotype Database for KD</GrantOrContributionPurposeTxt>
          <Amt>235000</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>Mayo Clinic</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>200 First Street SW</AddressLine1Txt>
            <CityNm>Rochester</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55905</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Elucidating the Metabolic Signature of KD Plasma, Dried Blood Spots, and Cerebrospinal Fluid Using Flux Analysis</GrantOrContributionPurposeTxt>
          <Amt>55359</Amt>
        </GrantOrContriApprvForFutGrp>
        <GrantOrContriApprvForFutGrp>
          <RecipientPersonNm>UW Department of Pediatrics</RecipientPersonNm>
          <RecipientUSAddress>
            <AddressLine1Txt>600 Highland Avenue</AddressLine1Txt>
            <CityNm>Madison</CityNm>
            <StateAbbreviationCd>WI</StateAbbreviationCd>
            <ZIPCd>53792</ZIPCd>
          </RecipientUSAddress>
          <RecipientRelationshipTxt>N/A</RecipientRelationshipTxt>
          <RecipientFoundationStatusTxt>PC</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>Enriching CF Newborn Screening Outcomes Through a Precision Personalized Medicine Strategy</GrantOrContributionPurposeTxt>
          <Amt>250000</Amt>
        </GrantOrContriApprvForFutGrp>
        <TotalGrantOrContriApprvFutAmt>1500359</TotalGrantOrContriApprvFutAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>2519</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>992668</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>922157</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <OtherRevenueDescribedGrp>
          <Desc>Returned Grants</Desc>
          <ExclusionCd>1</ExclusionCd>
          <ExclusionAmt>11262</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>Settlement Proceeds</Desc>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>6261565</ExclusionAmt>
        </OtherRevenueDescribedGrp>
        <SubtotalsIncmProducingActyGrp>
          <ExclusionAmt>8190171</ExclusionAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>8190171</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>false</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>false</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>false</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>false</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>false</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>false</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>false</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>false</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>false</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>false</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <IRS990ScheduleB documentId="IRS990ScheduleB" softwareId="24020490" softwareVersionNum="2024v5.2">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <GeneralRuleInd>X</GeneralRuleInd>
      <ContributorInformationGrp>
        <ContributorNum>1</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1Txt>Forge Biologics Inc</BusinessNameLine1Txt>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1Txt>3900 Gantz Rd</AddressLine1Txt>
          <CityNm>Grove City</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>43123</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>5000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
      <ContributorInformationGrp>
        <ContributorNum>2</ContributorNum>
        <ContributorPersonNm>Paul Rosenau</ContributorPersonNm>
        <ContributorUSAddress>
          <AddressLine1Txt>21656 Mushtown Road</AddressLine1Txt>
          <CityNm>Prior Lake</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55372</ZIPCd>
        </ContributorUSAddress>
        <TotalContributionsAmt>40000</TotalContributionsAmt>
        <PersonContributionInd>X</PersonContributionInd>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <AccountingFeesSchedule documentId="AccountingFeesSchedule" softwareId="24020490" softwareVersionNum="2024v5.2">
      <AccountingFeesDetail>
        <CategoryTxt>Dufault CPA Ltd</CategoryTxt>
        <Amt>17960</Amt>
        <NetInvestmentIncomeAmt>17960</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <InvestmentsCorpStockSchedule documentId="InvestmentsCorpStockSchedule" softwareId="24020490" softwareVersionNum="2024v5.2">
      <InvestmentsCorporateStockGrp>
        <StockNm>43,770.766 shs US Large Cap Value III</StockNm>
        <EOYBookValueAmt>982081</EOYBookValueAmt>
        <EOYFMVAmt>1385782</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>16,505.927 shs US Small-Cap Value Port</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>19,682.000 shs Short-Term Treasury</StockNm>
        <EOYBookValueAmt>1142361</EOYBookValueAmt>
        <EOYFMVAmt>1145099</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>15,741.072 shs Intl Value III Port</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>54,110.610 shs US High Relative Prof</StockNm>
        <EOYBookValueAmt>644827</EOYBookValueAmt>
        <EOYFMVAmt>1324628</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>44,730.247 shs Emerging Mkts Core</StockNm>
        <EOYBookValueAmt>859453</EOYBookValueAmt>
        <EOYFMVAmt>1041320</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>303,313.168 shs Baird Core Plus Bond Fd</StockNm>
        <EOYBookValueAmt>3468652</EOYBookValueAmt>
        <EOYFMVAmt>3036165</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>115,785.191 shs Two Year Global Fixed</StockNm>
        <EOYBookValueAmt>1153465</EOYBookValueAmt>
        <EOYFMVAmt>1125432</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>236,769.478 shs Intmd Term Invmt Grade</StockNm>
        <EOYBookValueAmt>2333011</EOYBookValueAmt>
        <EOYFMVAmt>2026747</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>20,363.000 shs Intl Fd FTSE Dev Mkt ETF</StockNm>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>14,663.000 shs US Small-Cap Value ETF</StockNm>
        <EOYBookValueAmt>1284413</EOYBookValueAmt>
        <EOYFMVAmt>1415419</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>22,706.000 shs Total Stk Mkt ETF</StockNm>
        <EOYBookValueAmt>4371494</EOYBookValueAmt>
        <EOYFMVAmt>6580426</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>42,452.000 shs Total Bnd Mrkt ETF</StockNm>
        <EOYBookValueAmt>3522610</EOYBookValueAmt>
        <EOYFMVAmt>3052723</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>37,256.000 shs Inter-Term Treasury</StockNm>
        <EOYBookValueAmt>2205605</EOYBookValueAmt>
        <EOYFMVAmt>2160848</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>9,447.000 shs Intl Small-Cap Value ETF</StockNm>
        <EOYBookValueAmt>588313</EOYBookValueAmt>
        <EOYFMVAmt>614811</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>7,310.000 shs USA Quality Factor ETF</StockNm>
        <EOYBookValueAmt>1082082</EOYBookValueAmt>
        <EOYFMVAmt>1301765</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>13,065.000 shs USA Value Factor ETF</StockNm>
        <EOYBookValueAmt>1303567</EOYBookValueAmt>
        <EOYFMVAmt>1379795</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>4,497.000 shs USA Momentum Factor ETF</StockNm>
        <EOYBookValueAmt>712781</EOYBookValueAmt>
        <EOYFMVAmt>930519</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>23,868.000 shs Emerging Mkts ETF</StockNm>
        <EOYBookValueAmt>1196742</EOYBookValueAmt>
        <EOYFMVAmt>1246387</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>23,607.000 shs Ultra Short-Term Bd ETF</StockNm>
        <EOYBookValueAmt>1185104</EOYBookValueAmt>
        <EOYFMVAmt>1190501</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>43,293.000 shs Intl Developed Mkts ETF</StockNm>
        <EOYBookValueAmt>2731752</EOYBookValueAmt>
        <EOYFMVAmt>2791100</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>51,544.000 shs Intl Value Factor ETF</StockNm>
        <EOYBookValueAmt>1379974</EOYBookValueAmt>
        <EOYFMVAmt>1397358</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>225,000.000 shs Government Money Market</StockNm>
        <EOYBookValueAmt>225000</EOYBookValueAmt>
        <EOYFMVAmt>225000</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <InvestmentsOtherSchedule2 documentId="InvestmentsOtherSchedule2" softwareId="24020490" softwareVersionNum="2024v5.2">
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>Principal Life Ins #6113382</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>691000</BookValueAmt>
        <EOYFMVAmt>742468</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>Principal Life Ins #6531775</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>675000</BookValueAmt>
        <EOYFMVAmt>600256</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>Principal Life Ins #5121520</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>500000</BookValueAmt>
        <EOYFMVAmt>620103</EOYFMVAmt>
      </InvestmentsOtherGrp>
      <InvestmentsOtherGrp>
        <CategoryOrItemTxt>Principal Life Ins #5121519</CategoryOrItemTxt>
        <ListedAtCostOrFMVCd>AT COST</ListedAtCostOrFMVCd>
        <BookValueAmt>389922</BookValueAmt>
        <EOYFMVAmt>344489</EOYFMVAmt>
      </InvestmentsOtherGrp>
    </InvestmentsOtherSchedule2>
    <LegalFeesSchedule documentId="LegalFeesSchedule" softwareId="24020490" softwareVersionNum="2024v5.2">
      <LegalFeesGrp>
        <CategoryTxt>Belin McCormick PC</CategoryTxt>
        <LegalFeesAmt>11785</LegalFeesAmt>
        <NetInvestmentIncomeAmt>11785</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Fiduciary Insurance Advisors Inc</CategoryTxt>
        <LegalFeesAmt>14475</LegalFeesAmt>
        <NetInvestmentIncomeAmt>14475</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>FINRA</CategoryTxt>
        <LegalFeesAmt>12900</LegalFeesAmt>
        <NetInvestmentIncomeAmt>12900</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Heley Duncan &amp; Melander PLLP</CategoryTxt>
        <LegalFeesAmt>308713</LegalFeesAmt>
        <NetInvestmentIncomeAmt>308713</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Larkin Hoffman Attorneys</CategoryTxt>
        <LegalFeesAmt>3566</LegalFeesAmt>
        <NetInvestmentIncomeAmt>3566</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Larson King</CategoryTxt>
        <LegalFeesAmt>359491</LegalFeesAmt>
        <NetInvestmentIncomeAmt>359491</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>Sikowitz Economic Consulting LLC</CategoryTxt>
        <LegalFeesAmt>16632</LegalFeesAmt>
        <NetInvestmentIncomeAmt>16632</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
      <LegalFeesGrp>
        <CategoryTxt>SLCG Economic Consulting LLC</CategoryTxt>
        <LegalFeesAmt>36121</LegalFeesAmt>
        <NetInvestmentIncomeAmt>36121</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
    </LegalFeesSchedule>
    <OtherDecreasesSchedule documentId="OtherDecreasesSchedule" softwareId="24020490" softwareVersionNum="2024v5.2">
      <OtherDecreasesDetail>
        <Desc>Increase in Grants Payable</Desc>
        <Amt>160669</Amt>
      </OtherDecreasesDetail>
    </OtherDecreasesSchedule>
    <OtherExpensesSchedule documentId="OtherExpensesSchedule" softwareId="24020490" softwareVersionNum="2024v5.2">
      <OtherExpensesScheduleGrp>
        <Desc>Bank Charges</Desc>
        <RevenueAndExpensesPerBooksAmt>807</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>807</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Business Meals</Desc>
        <RevenueAndExpensesPerBooksAmt>5814</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>2907</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Contract Services</Desc>
        <RevenueAndExpensesPerBooksAmt>194431</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>194431</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Dues &amp; Subscriptions</Desc>
        <RevenueAndExpensesPerBooksAmt>9749</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>9749</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Events</Desc>
        <RevenueAndExpensesPerBooksAmt>27500</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>27500</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Insurance</Desc>
        <RevenueAndExpensesPerBooksAmt>8272</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>8272</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>KTRN Meeting</Desc>
        <RevenueAndExpensesPerBooksAmt>61103</RevenueAndExpensesPerBooksAmt>
        <DisbursementsCharitablePrpsAmt>61103</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Media</Desc>
        <RevenueAndExpensesPerBooksAmt>22081</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>22081</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Miscellaneous Expense</Desc>
        <RevenueAndExpensesPerBooksAmt>176</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>176</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Office Expense</Desc>
        <RevenueAndExpensesPerBooksAmt>960</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>960</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>Postage &amp; Delivery</Desc>
        <RevenueAndExpensesPerBooksAmt>347</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>347</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="OtherIncomeSchedule2" softwareId="24020490" softwareVersionNum="2024v5.2">
      <OtherIncomeDetail>
        <Desc>Returned Grants</Desc>
        <RevenueAndExpensesPerBooksAmt>11262</RevenueAndExpensesPerBooksAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>Settlement Proceeds</Desc>
        <RevenueAndExpensesPerBooksAmt>6261565</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>6261565</NetInvestmentIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherProfessionalFeesSchedule documentId="OtherProfessionalFeesSchedule" softwareId="24020490" softwareVersionNum="2024v5.2">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>Flagship Insurance Services</CategoryTxt>
        <Amt>1260</Amt>
        <NetInvestmentIncomeAmt>1260</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>Foster Group Inc</CategoryTxt>
        <Amt>95777</Amt>
        <NetInvestmentIncomeAmt>95777</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
      <OtherProfessionalFeesDetail>
        <CategoryTxt>Other Professional Fees</CategoryTxt>
        <Amt>9000</Amt>
        <NetInvestmentIncomeAmt>9000</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <TaxesSchedule documentId="TaxesSchedule" softwareId="24020490" softwareVersionNum="2024v5.2">
      <TaxesDetail>
        <CategoryTxt>Federal Excise Taxes</CategoryTxt>
        <Amt>90000</Amt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>Foreign Income Taxes</CategoryTxt>
        <Amt>17808</Amt>
        <NetInvestmentIncomeAmt>17808</NetInvestmentIncomeAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>